secwatch.observer — SEC 8-K summary
======================================

Issuer:     Cabaletta Bio, Inc. (CABA)
CIK:        0001759138
Form:       8-K
Filed at:   2023-05-22T23:59:59+00:00
Accession:  0001193125-23-150530
Event type: other_material
Sentiment:  neutral
Materiality: 0.65
Item codes: 8.01, 9.01
LLM model:  deepseek-v4-flash:cloud@v2

Cabaletta Bio closes $100M public offering of 8.34M shares at $12.00/share
--------------------------------------------------------------------------

- Gross proceeds of approximately $100 million from sale of 8,337,500 shares, including full exercise of underwriters' option for 1,087,500 additional shares.
- Price of shares was $12.00 per share, before underwriting discounts and commissions.
- Joint book-running managers: TD Cowen, Evercore ISI, Guggenheim Securities; lead manager H.C. Wainwright & Co.
- Company expects net proceeds plus existing cash to fund operations into Q4 2025.

Source:
  EDGAR index:    https://www.sec.gov/Archives/edgar/data/1759138/000119312523150530/0001193125-23-150530-index.htm
  Primary doc:    https://www.sec.gov/Archives/edgar/data/1759138/000119312523150530/d470858d8k.htm
  HTML page:      https://secwatch.observer/filing/0001193125-23-150530

License: Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer